NCT06083116View on ClinicalTrials.gov

Drug-Drug Interaction Study Between Henagliflozin Proline and Hydrochlorothiazide

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 28, 2019

Primary Completion Date

October 10, 2019

Study Completion Date

October 10, 2019

Conditions
Diabetes in Adults
Interventions
DRUG

Hydrochlorothiazide、Henagliflozin Proline

Hydrochlorothiazide and Henagliflozin Proline

Trial Locations (1)

200031

Shanghai Xuhui Central Hospital, Shanghai

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT06083116 - Drug-Drug Interaction Study Between Henagliflozin Proline and Hydrochlorothiazide | Biotech Hunter | Biotech Hunter